Breaking Traditional Barriers: Harnessing Multi-Organ-on-Chip and Gut-Lung Axis Models to Map the Neuroimmune Power of Live Biotherapeutic Products
The therapeutic landscape is undergoing a conceptual shift as researchers move beyond single-target drugs to embrace the systemic complexity of Live Biotherapeutic Products (LBPs). No longer dismissed as mere digestive aids, next-generation probiotics and engineered live microbes are now recognized as powerful systemic regulators capable of modulating distant organs. However, mapping how a...
0 Kommentare 0 Geteilt 49 Ansichten 0 Bewertungen